Antibiotic prophylaxis for GI endoscopy

Gastrointestinal Endoscopy

Volumn 67, Issue 6, 2008, Pages 791-798

  Banerjee, Subhas ^a   Shen, Bo ^a   Baron, Todd H ^a   Nelson, Douglas B ^a   Anderson, Michelle A ^a   Cash, Brooks D ^a   Dominitz, Jason A ^a   Gan, S Ian ^a   Harrison, M Edwyn ^a   Ikenberry, Steven O ^a   Jagannath, Sanjay B ^a   Lichtenstein, David ^a   Fanelli, Robert D ^a   Lee, Ken ^a   van Guilder, Trina ^a   Stewart, Leslie E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; NORFLOXACIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL TRANSLOCATION; BLOOD VESSEL GRAFT; DEVICE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HUMAN; LIVER CIRRHOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; PRIORITY JOURNAL;

ANTIBIOTIC PROPHYLAXIS; CROSS INFECTION; ENDOSCOPY, GASTROINTESTINAL; HUMANS;

EID: 42749097015     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2008.02.068     Document Type: Article

References (70)

1. Seeff L.C., Richards T.B., Shapiro J.A., et al. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity. Gastroenterology 127 (2004) 1670-1677
2. Zuccaro Jr. G., Richter J.E., Rice T.W., et al. Viridans streptococcal bacteremia after esophageal stricture dilation. Gastrointest Endosc 48 (1998) 568-573
3. Nelson D.B., Sanderson S.J., and Azar M.M. Bacteremia with esophageal dilation. Gastrointest Endosc 48 (1998) 563-567
4. Hirota W.K., Wortmann G.W., Maydonovitch C.L., et al. The effect of oral decontamination with clindamycin palmitate on the incidence of bacteremia after esophageal dilation: a prospective trial. Gastrointest Endosc 50 (1999) 475-479
5. Camara D.S., Gruber M., Barde C.J., et al. Transient bacteremia following endoscopic injection sclerotherapy of esophageal varices. Arch Intern Med 143 (1983) 1350-1352
6. Cohen L.B., Korsten M.A., Scherl E.J., et al. Bacteremia after endoscopic injection sclerosis. Gastrointest Endosc 29 (1983) 198-200
7. Brayko C.M., Kozarek R.A., Sanowski R.A., et al. Bacteremia during esophageal variceal sclerotherapy: its cause and prevention. Gastrointest Endosc 31 (1985) 10-12
8. Snady H., Korsten M.A., and Waye J.D. The relationship of bacteremia to the length of injection needle in endoscopic variceal sclerotherapy. Gastrointest Endosc 31 (1985) 243-246
9. Lo G.H., Lai K.H., Shen M.T., et al. A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc 40 (1994) 675-679
10. Lo G.H., Lai K.H., Cheng J.S., et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 22 (1995) 466-471
11. Tseng C.C., Green R.M., Burke S.K., et al. Bacteremia after endoscopic band ligation of esophageal varices. Gastrointest Endosc 38 (1992) 336-337
12. Berner J.S., Gaing A.A., Sharma R., et al. Sequelae after esophageal variceal ligation and sclerotherapy: a prospective randomized study. Am J Gastroenterol 89 (1994) 852-858
13. Lin O.S., Wu S.S., Chen Y.Y., et al. Bacterial peritonitis after elective endoscopic variceal ligation: a prospective study. Am J Gastroenterol 95 (2000) 214-217
14. da Silveira Rohr M.R., Siqueira E.S., Brant C.Q., et al. Prospective study of bacteremia rate after elastic band ligation and sclerotherapy of esophageal varices in patients with hepatosplenic schistosomiasis. Gastrointest Endosc 46 (1997) 321-323
15. Nelson D.B. Infectious disease complications of GI endoscopy: part I, endogenous infections. Gastrointest Endosc 57 (2003) 546-556
16. Linnemann C., Weisman E., and Wenger J. Blood cultures following endoscopy of the esophagus and stomach. South Med J 64 (1971) 1055 passim
17. Shull Jr. H.J., Greene B.M., Allen S.D., et al. Bacteremia with upper gastrointestinal endoscopy. Ann Intern Med 83 (1975) 212-214
18. Liebermann T.R. Bacteremia and fiberoptic endoscopy. Gastrointest Endosc 23 (1976) 36-37
19. Mellow M.H., and Lewis R.J. Endoscopy-related bacteremia. Incidence of positive blood cultures after endoscopy of upper gastrointestinal tract. Arch Intern Med 136 (1976) 667-669
20. Baltch A.L., Buhac I., Agrawal A., et al. Bacteremia after upper gastrointestinal endoscopy. Arch Intern Med 137 (1977) 594-597
21. Stray N., Midtvedt T., Valnes K., et al. Endoscopy-related bacteremia. Scand J Gastroenterol 13 (1978) 345-347
22. Kirk A., Graham-Brown R., Perinpanayagam R.M., et al. Bacteraemia and upper gastrointestinal fibre-endoscopy. J Royal Soc Med 72 (1979) 409-411
23. Norfleet R.G., Mitchell P.D., Mulholland D.D., et al. Does bacteremia follow upper gastrointestinal endoscopy?. Am J Gastroenterol 76 (1981) 420-422
24. O'Connor H.J., Hamilton I., Lincoln C., et al. Bacteraemia with upper gastrointestinal endoscopy: a reappraisal. Endoscopy 15 (1983) 21-23
25. Goldman G.D., Miller S.A., Furman D.S., et al. Does bacteremia occur during flexible sigmoidoscopy?. Am J Gastroenterol 80 (1985) 621-623
26. Llach J., Elizalde J.I., Bordas J.M., et al. Prospective assessment of the risk of bacteremia in cirrhotic patients undergoing lower intestinal endoscopy. Gastrointest Endosc 49 (1999) 214-217
27. Barawi M., Gottlieb K., Cunha B., et al. A prospective evaluation of the incidence of bacteremia associated with EUS-guided fine-needle aspiration. Gastrointest Endosc 53 (2001) 189-192
28. Levy M.J., Norton I.D., Wiersema M.J., et al. Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA. Gastrointest Endosc 57 (2003) 672-678
29. Janssen J., Konig K., Knop-Hammad V., et al. Frequency of bacteremia after linear EUS of the upper GI tract with and without FNA. Gastrointest Endosc 59 (2004) 339-344
30. Adler D.G., Jacobson B.C., Davila R.E., et al. ASGE guideline: complications of EUS. Gastrointest Endosc 61 (2005) 8-12
31. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 116 (2007) 1736-1754
32. American Society for Gastrointestinal Endoscopy. Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 58 (2003) 475-482
33. Gould F.K., Elliott T.S., Foweraker J., et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 57 (2006) 1035-1042
34. Ramsdale D.R., and Turner-Stokes L. Advisory Group of the British Cardiac Society Clinical Practice Committee, et al. Prophylaxis and treatment of infective endocarditis in adults: a concise guide. Clin Med 4 (2004) 545-550
35. Roduit J., Jornod P., Dorta N., et al. Antibiotic prophylaxis of infective endocarditis during digestive endoscopy: over- and underuse in Switzerland despite professed adherence to guidelines. Endoscopy 34 (2002) 322-324
36. Snyder J., and Bratton B. Antimicrobial prophylaxis for gastrointestinal procedures: current practices in North American academic pediatric programs. J Pediatr Gastroenterol Nutr 35 (2002) 564-569
37. Bilbao M.K., Dotter C.T., Lee T.G., et al. Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases. Gastroenterology 70 (1976) 314-320
38. Deviere J., Motte S., Dumonceau J.M., et al. Septicemia after endoscopic retrograde cholangiopancreatography. Endoscopy 22 (1990) 72-75
39. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 335 (1996) 909-918
40. Loperfido S., Angelini G., Benedetti G., et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48 (1998) 1-10
41. Masci E., Toti G., Mariani A., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96 (2001) 417-423
42. Sauter G., Grabein B., Huber G., et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy 22 (1990) 164-167
43. Niederau C., Pohlmann U., Lubke H., et al. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc 40 (1994) 533-537
44. Harris A., Chan A.C., Torres-Viera C., et al. Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 31 (1999) 718-724
45. Subhani J.M., Kibbler C., and Dooley J.S. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 13 (1999) 103-116
46. Motte S., Deviere J., Dumonceau J.M., et al. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 101 (1991) 1374-1381
47. De Palma G.D., Galloro G., Siciliano S., et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 53 (2001) 547-553
48. van den Hazel S.J., Speelman P., Dankert J., et al. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Intern Med 125 (1996) 442-447
49. Byl B., Deviere J., Struelens M.J., et al. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: a randomized, double-blind, placebo-controlled study. Clin Infect Dis 20 (1995) 1236-1240
50. American Society for Gastrointestinal Endoscopy, Jacobson B.C., Baron T.H., et al. ASGE guideline: the role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc 61 (2005) 363-370
51. Cotton P.B., Connor P., Rawls E., et al. Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc 67 (2008) 471-475
52. Williams D.B., Sahai A.V., Aabakken L., et al. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 44 (1999) 720-726
53. Eloubeidi M.A., Tamhane A., Varadarajulu S., et al. Frequency of major complications after EUS-guided FNA of solid pancreatic masses: a prospective evaluation. Gastrointest Endosc 63 (2006) 622-629
54. Wiersema M.J., Vilmann P., Giovannini M., et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 112 (1997) 1087-1095
55. Sing Jr. J., Erickson R., and Fader R. An in vitro analysis of microbial transmission during EUS-guided FNA and the utility of sterilization agents. Gastrointest Endosc 64 (2006) 774-779
56. Wildi S.M., Hoda R.S., Fickling W., et al. Diagnosis of benign cysts of the mediastinum: the role and risks of EUS and FNA. Gastrointest Endosc 58 (2003) 362-368
57. Ryan A.G., Zamvar V., and Roberts S.A. Iatrogenic candidal infection of a mediastinal foregut cyst following endoscopic ultrasound-guided fine-needle aspiration. Endoscopy 34 (2002) 838-839
58. Lee L.S., Saltzman J.R., Bounds B.C., et al. EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors. Clin Gastroenterol Hepatol 3 (2005) 231-236
59. Schwartz D.A., Harewood G.C., and Wiersema M.J. EUS for rectal disease. Gastrointest Endosc 56 (2002) 100-109
60. Levy M.J., Norton I.D., Clain J.E., et al. Prospective study of bacteremia and complications with EUS FNA of rectal and perirectal lesions. Clin Gastroenterol Hepatol 5 (2007) 684-689
61. Lipp A., and Lusardi G. Systemic antimicrobial prophylaxis for percutaneous endoscopic gastrostomy. Cochrane Database of Systematic Reviews (2006) CD005571
62. Jain N.K., Larson D.E., Schroeder K.W., et al. Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial. Ann Intern Med 107 (1987) 824-828
63. Thomas S., Cantrill S., Waghorn D.J., et al. The role of screening and antibiotic prophylaxis in the prevention of percutaneous gastrostomy site infection caused by methicillin-resistant Staphylococcus aureus. Aliment Pharmacol Ther 25 (2007) 593-597
64. Soares-Weiser K., Brezis M., Tur-Kaspa R., et al. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev (2002) CD002907
65. Fernandez J., Ruiz del Arbol L., Gomez C., et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131 (2006) 1049-1056 quiz 1285
66. Baddour L.M., Bettmann M.A., Bolger A.F., et al. Nonvalvular cardiovascular device-related infections. Circulation 108 (2003) 2015-2031
67. Scott N.A., and Tweedle D.E. Pyogenic arthritis of the knee following Nd:YAG laser destruction of an esophageal cancer. Gastrointest Endosc 36 (1990) 545-546
68. Vanderhooft J.E., and Robinson R.P. Late infection of a bipolar prosthesis following endoscopy. A case report. J Bone Joint Surg Am 76 (1994) 744-746
69. Meyer G.W., and Artis A.L. Antibiotic prophylaxis for orthopedic prostheses and GI procedures: report of a survey. Am J Gastroenterol 92 (1997) 989-991
70. Rattner D., Kalloo A., and Group A.S.W. ASGE/SAGES Working Group on Natural Orifice Translumenal Endoscopic Surgery. October 2005. Surg Endosc 20 (2006) 329-333